US News & World Report - January 28, 2020
A U.S. News & World Report article encourages prospective medical school applicants to read medical school blogs to get a sense of how students and physicians feel about the training process and the practice of medicine. Among the blogs named was The Doctor's Tablet, Einstein's award-winning blog featuring posts by faculty, researchers, physicians, and current students. The blog’s co-editors are Gordon Earle, associate dean for communications and public affairs, and David Flores, director of social media.
US News & World Report - January 27, 2020
Michael Lipton, M.D., Ph.D., explains his published research suggesting that a gene variant, APOE-e4, increases the risk for cognitive impairment among amateur soccer players who most frequently head the ball. Dr. Lipton is professor of radiology and associate director of the Gruss Magnetic Resonance Research Center at Einstein, and director of MRI Services at Montefiore.
More CoverageDr. Lipton's ProfileMore coverage on Dr. Lipton
NPR - January 2, 2020
William Jacobs Jr., Ph.D., comments on a study in which high doses of the tuberculosis vaccine injected directly into the bloodstream of monkeys provided nearly complete immunity to the disease. Dr. Jacobs is professor of microbiology & immunology and of genetics and the Leo and Julia Forchheimer Chair in Microbiology & Immunology at Einstein.
Dr. Jacobs' ProfileMore coverage on Dr. Jacobs
US News & World Report - December 31, 2019
Sarah Baron, M.D., comments on her study that found nearly one in 10 patients admitted to the hospital are already infected with Clostridioides difficile, a bacterium that causes severe diarrhea and 30,000 deaths each year in the U.S. and has long been thought to be acquired while in the hospital. Dr. Baron is assistant professor of medicine at Einstein and an internist at Montefiore.
Dr. Baron's Profile
The Guardian - December 21, 2019
Nir Barzilai, M.D., describes his planned clinical trial that will study the effects of metformin, a drug used to treat diabetes, on aging. Dr. Barzilai is the Ingeborg and Ira Leon Rennert Chair in Aging Research and director of the Institute for Aging Research at Einstein and an endocrinologist at Montefiore.
Dr. Barzilai's ProfileMore coverage on Dr. Barzilai
The Washington Post - December 19, 2019
Lisa Shulman, M.D., comments on her research that found most children who “lose” an autism diagnosis continue to need therapeutic and educational support for language and learning disabilities and emotional and behavioral problems. Dr. Shulman is professor of pediatrics at Einstein and interim director of the Rose F. Kennedy Children’s Evaluation and Rehabilitation Center at Montefiore.
Dr. Shulman's ProfileMore coverage on Dr. Shulman
Associated Press - December 18, 2019
Aaron Fox, M.D., M.S., is leading a study to determine if a “medication-first” approach to treating opioid use disorder, which uses buprenorphine to control withdrawal symptoms, is more effective than the current standard of care, which focuses on counseling. Dr. Fox is associate professor of medicine at Einstein and an internist at Montefiore.
Dr. Fox's Faculty Profile
Science - December 14, 2019
Aristea Galanopoulou, M.D., Ph.D., is studying traumatic brain injuries to find biomarkers that may indicate who is at increased risk of developing epilepsy. Dr. Galanopoulou is professor in the Saul R. Korey Department of Neurology and in the Dominick P. Purpura Department of Neuroscience at Einstein and a neurologist at Montefiore.
Dr. Galanopoulou's Profile
The New York Times - December 14, 2019
Elina Jerschow, M.D., M.S., who studies adverse reactions to medications, diagnosed a patient with aspirin-exacerbated respiratory disease (AERD) after the patient suffered a severe asthma attack and developed a severe reaction to select pain medications. Dr. Jerschow is associate professor of medicine and of microbiology & immunology at Einstein and director of the Montefiore AERD and Drug Allergy Center.
Dr. Jerschow's ProfileMore coverage on Dr. Jerschow
Medscape - December 13, 2019
In the third segment of a four-part series, Jill Crandall, M.D. explains the progression of type 2 diabetes, the risk of complications, and the importance of insulin therapy to manage the disease. Dr. Crandall is chief of the division of endocrinology at Einstein and Montefiore.
Dr. Crandall's ProfileMore coverage on Dr. Crandall
Medscape - December 13, 2019
Michael Lipton, M.D., Ph.D., discusses his study, presented as an abstract at the Radiological Society of North America annual meeting, on the association between oral contraception use and the size of the brain’s hypothalamus. Dr. Lipton is professor of radiology and associate director of the Gruss Magnetic Resonance Research Center at Einstein, and director of MRI Services at Montefiore.
More CoverageDr. Lipton's ProfileMore coverage on Dr. Lipton
US News & World Report - December 13, 2019
Chaim Putterman, M.D., writes about new lupus research in which scientists examine individual cells from diseased organs to identify genetic “signatures” that may be driving a patient’s disease. Dr. Putterman is chief of the division of rheumatology at Einstein and Montefiore.
Dr. Putterman's ProfileMore coverage on Dr. Putterman